Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1/2, Open-Label, Dose-Escalation and Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies
Active
$277.3K Funding
5 People
External
Related Topics
cancer,
drug development,
clinical trial,
molecular biology,
oncology
People
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
Abhijeet Kumar
Principal Investigator (PI)
Medicine
﹒Associate Professor, Medicine - (Clinical Scholar Track)
Michele Chu-Pilli
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Patricia Robles Quihuis
(CD)
Cancer Center Division
﹒Research Nurse III
